Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression

Published 2016 View Full Article

Authors

Keywords

asclepiasterol, steroid, multidrug resistance (MDR), P-glycoprotein, phosphorylation of ERK1/2 (P-ERK)

Journal

Oncotarget

Volume 7, Issue 21, Pages -

Publisher

Impact Journals, LLC

Online

2016-04-25

DOI

10.18632/oncotarget.8965

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.